Saved in:
Bibliographic Details
Main Author: Taye, Mesfin
Format: Preprint
Published: 2025
Subjects:
Online Access:https://arxiv.org/abs/2503.19665
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866918137880903680
author Taye, Mesfin
author_facet Taye, Mesfin
contents Due to the persistence of latently infected CD4$^+$ T cells, achieving a functional cure for HIV-1 remains a significant challenge since the viruses are able to evade immune clearance, which in turn enables post-treatment viral rebound. Because traditional deterministic models assume a constant reactivation rate, they fail to capture the stochastic nature of latency reversal influenced by immune perturbations and ART pharmacokinetics. Thus, in this study, by using a Poisson-driven stochastic framework that incorporates fluctuations in activation rates, we study viral rebound dynamics. Via an exponentially decreasing drug washout model, we accurately quantifies the nonlinear interplay between ART decay and stochastic reactivation, improving the theoretical estimates of post-treatment control. Beyond the introduction of stochasticity, our model establishes a time-dependent viral reactivation framework that integrates periodic and random perturbations in the activation rates. Unlike conventional models that assume uniform (temporally independent reactivation), we show that latency reversal follows structured oscillatory patterns modulated by immune cycles, circadian rhythms, and transient inflammatory episodes. This finding suggests that viral rebound risk is dynamically shaped by immune fluctuations, contrary to the assumption of a constant reactivation probability. We also study the model system by incorporating Gamma-distributed waiting times to account for heterogeneity in reactivation kinetics, which in turn provides a more flexible characterization of reservoir dynamics. We believe that these insights have critical implications for HIV cure strategies.
format Preprint
id arxiv_https___arxiv_org_abs_2503_19665
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Drug Washout and Viral Rebound: Modeling HIV Reactivation Under ART Discontinuation
Taye, Mesfin
Biological Physics
Due to the persistence of latently infected CD4$^+$ T cells, achieving a functional cure for HIV-1 remains a significant challenge since the viruses are able to evade immune clearance, which in turn enables post-treatment viral rebound. Because traditional deterministic models assume a constant reactivation rate, they fail to capture the stochastic nature of latency reversal influenced by immune perturbations and ART pharmacokinetics. Thus, in this study, by using a Poisson-driven stochastic framework that incorporates fluctuations in activation rates, we study viral rebound dynamics. Via an exponentially decreasing drug washout model, we accurately quantifies the nonlinear interplay between ART decay and stochastic reactivation, improving the theoretical estimates of post-treatment control. Beyond the introduction of stochasticity, our model establishes a time-dependent viral reactivation framework that integrates periodic and random perturbations in the activation rates. Unlike conventional models that assume uniform (temporally independent reactivation), we show that latency reversal follows structured oscillatory patterns modulated by immune cycles, circadian rhythms, and transient inflammatory episodes. This finding suggests that viral rebound risk is dynamically shaped by immune fluctuations, contrary to the assumption of a constant reactivation probability. We also study the model system by incorporating Gamma-distributed waiting times to account for heterogeneity in reactivation kinetics, which in turn provides a more flexible characterization of reservoir dynamics. We believe that these insights have critical implications for HIV cure strategies.
title Drug Washout and Viral Rebound: Modeling HIV Reactivation Under ART Discontinuation
topic Biological Physics
url https://arxiv.org/abs/2503.19665